Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of TVAX-028 in the Treatment of Chronic Hepatitis B

This is a multicenter, open-label, non-randomized, Phase 1 clinical study with single-dose and multiple-dose dose-escalation cohorts. The study is designed to evaluate the safety, tolerability, and pharmacokinetic characteristics of TVAX-028 in patients with chronic hepatitis B virus infection

Participants needed: 32
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Grand Theravac Life Sciences (Nanjing) Co., Ltd.Updated: Jun 29, 2026
Eligibility criteria

1. Subjects voluntarily sign the informed consent, fully understand the study co... [+7]

1. Has liver disease other than chronic hepatitis B virus infection that may int... [+17]

Status: Not yet recruiting

Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in the Treatment of Chronic Hepatitis B

This is a multicenter, randomized, placebo-controlled (double-blind design) versus active-controlled (open-label design) Phase I clinical trial evaluating the efficacy and safety of TVAX-008 injection in subjects with chronic hepatitis B.

Participants needed: 630
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Grand Theravac Life Sciences (Nanjing) Co., Ltd.Updated: Dec 15, 2025
Eligibility criteria

Male or female, aged 18 to 65 years (inclusive); [+6]

Liver disease caused by other causes, including alcoholic liver disease, nonalco... [+26]